Scientists from five institutions, including Northwestern, discovered a cancer-specific biomarker found in all stages of breast, prostate and pancreatic cancers.
Marcus Peter, PhD, professor in Medicine-Hematology/Oncology, has discovered how the removal of a known “tumor suppressor” causes cancer cells to kill themselves.
M. Marsel Mesulam, MD, director of the Cognitive Neurology and Alzheimer’s Disease Center, will travel to Philadelphia at the end of April to be honored at the annual American Academy of Neurology meeting.
Part of the $8 million multinational TumAdoR project, the study investigates the CD73 enzyme, which is overexpressed in many different forms of the disease.
Christian Stehlik and colleagues have learned how the molecular sensors that detect viruses and trigger defensive inflammatory responses are controlled.
The technique, used to measure blood flow in the heart and vessels, can also diagnose bicuspid aortic valve, a common congenital abnormality, and may lead to better prediction of complications.
Elevated blood pressure as young as age 18 is a warning sign of cardiovascular disease developing later in life and the time to begin prevention. That’s decades earlier than clinicians and patients generally start thinking about heart disease risk.
The discovery of an enzyme that is highly activated in cells from the joint fluid of rheumatoid arthritis patients may provide a new therapeutic target for the 1 million Americans affected by the disease.